Clinical Trials Directory

Trials / Unknown

UnknownNCT03113708

The Effect of Heparinization Due to LBW

The Effect of Heparinization Due to LBW in Cardiac Surgery

Status
Unknown
Phase
Phase 4
Study type
Interventional
Enrollment
50 (estimated)
Sponsor
Adiyaman University Research Hospital · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

High dose heparin regimens are required in cardiac surgery under cardiopulmonary bypass (CPB) and this may increase postoperative bleeding. The aim of this study is to evaluate the effect of heparin dose calculated according to lean body weight on intraoperative and postoperative bleeding.

Detailed description

Patients with preoperative demographic data such as age, gender, body weight, height, and additional disease, medications, previous surgery, preoperative Htc / Hb values were recorded in the operation room without medical premedication. Standard anesthesia induction was performed after arterial cannulation and peripheral venous route. Patients were randomly divided into two groups: 400 IU heparin / kg (Group I) and 400 IU heparin / kg (Group II) according to actual body weight and lean body weight respectively before CPB. Before and after heparin administration, CPB entry and ACT (Activated Clotting Time) values were counted every 30 minutes, after CPB exit and protamine. In both groups, supplemental heparin was administered when there was a failure to reach the pre-CPB target ACT value of 400 sec. Hemodynamic data and transfusion requirements were recorded during the operation. Patient's intraoperative CPB and crossover times, postoperative drainage volume and blood transfusion requirement were recorded.

Conditions

Interventions

TypeNameDescription
DRUGHeparin SodiumHeparinisation 2-4 mg/kg will be done according to actual body weight or lean body weight.

Timeline

Start date
2017-04-30
Primary completion
2017-05-20
Completion
2017-06-20
First posted
2017-04-13
Last updated
2017-04-14

Source: ClinicalTrials.gov record NCT03113708. Inclusion in this directory is not an endorsement.